Eli Lilly and Company CEO Returns to His Post

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Eli Lilly and Co said Chief Executive John Lechleiter returned to work after recovering from a surgery to treat a dilated aorta. Lechleiter, CEO since April 2008, was cleared by his personal physician and the company's employee health services physician to return to work, Eli Lilly said on Monday. Lechleiter's condition was discovered while undergoing certain unrelated tests, and he underwent the surgery on May 13.

Help employers find you! Check out all the jobs and post your resume.

Back to news